DermaER Psoriasis Therapeutic
- Product NDC
- 70794-207
- 11-digit product format
- 707940207
- Labeler code
- 70794
- Product ID
- 70794-207_f2a43e12-4853-db77-e053-2a95a90ab2bd
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Salicylic Acid
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Labeler
- Chen Cohen Industries Inc.
- Application
- M032
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2016-06-29
- Substance
- SALICYLIC ACID
- Active strength
- 20 mg/g
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 70794-207-17 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 70794-207-18 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 70794-207-16 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 70794-207-14 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 70794-207-17 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 70794-207-18 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 70794-207-16 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 70794-207-14 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 70794-207-17 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 70794-207-18 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 70794-207-16 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 70794-207-14 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 70794-207-17 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 70794-207-18 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 70794-207-16 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 70794-207-14 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 70794-207-17 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 70794-207-18 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 70794-207-16 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 70794-207-14 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 70794-207-17 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 70794-207-18 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 70794-207-16 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 70794-207-14 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 70794-207-17 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 70794-207-18 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 70794-207-16 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 70794-207-14 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 70794-207-17 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 70794-207-18 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 70794-207-16 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 70794-207-14 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 70794-207-17 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 70794-207-18 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 70794-207-16 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 70794-207-14 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 70794-207-17 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 70794-207-18 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 70794-207-16 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 70794-207-14 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 70794-207-17 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 70794-207-18 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 70794-207-16 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 70794-207-14 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 70794-207-17 | 834df4deac94… | adcc014656a3… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 70794-207-18 | 834df4deac94… | adcc014656a3… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 70794-207-16 | 834df4deac94… | adcc014656a3… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 70794-207-14 | 834df4deac94… | adcc014656a3… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- DermaER Psoriasis Therapeutic
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SALICYLIC ACID | 20 mg/g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| O414PZ4LPZ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 251400 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| f62e6c5e-6e80-4b75-a0b1-c893224d9ce4 | Available on FDA.report |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 70794-207-14 | 2025-05-28 | Drug Facts |
| 70794-207-16 | 2025-05-28 | Drug Facts |
| 70794-207-17 | 2025-05-28 | Drug Facts |
| 70794-207-18 | 2025-05-28 | Drug Facts |
| 70794-207-14 | 2023-01-30 | Drug Facts |
| 70794-207-16 | 2023-01-30 | Drug Facts |
| 70794-207-17 | 2023-01-30 | Drug Facts |
| 70794-207-18 | 2023-01-30 | Drug Facts |
| 70794-207-14 | 2020-02-18 | Drug Facts |
| 70794-207-16 | 2020-02-18 | Drug Facts |
| 70794-207-17 | 2020-02-18 | Drug Facts |
| 70794-207-18 | 2020-02-18 | Drug Facts |
| 70794-207-14 | 2020-01-31 | Drug Facts |
| 70794-207-16 | 2020-01-31 | Drug Facts |
| 70794-207-17 | 2020-01-31 | Drug Facts |
| 70794-207-18 | 2020-01-31 | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70794-207-14 | DermaER Psoriasis Therapeutic | 50 g in 1 TUBE | OINTMENT | 50 | 9 | |
| 70794-207-16 | DermaER Psoriasis Therapeutic | 59 g in 1 TUBE | OINTMENT | 59 | 9 | |
| 70794-207-17 | DermaER Psoriasis Therapeutic | 81 g in 1 TUBE | OINTMENT | 81 | 9 | |
| 70794-207-18 | DermaER Psoriasis Therapeutic | 103 g in 1 TUBE | OINTMENT | 103 | 9 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2 in 1 Dandruff | PYRITHIONE ZINC | Old East Main Co. | 1d4966d1-02d9-4b70-acc2-88a8190f920c | 2026-03-02 | Warnings, Adverse reactions | M032 |
| Pyrithione zinc | PYRITHIONE ZINC | Old East Main Co. | f17154e2-1bcf-43f9-b201-e84d374a0591 | 2026-03-02 | Warnings, Adverse reactions | M032 |
| 2 in 1 Dandruff | PYRITHIONE ZINC | Old East Main Co. | 61bf3788-b1e8-4d7e-ac56-cf209ba39085 | 2026-03-02 | Warnings, Adverse reactions | M032 |
| Everyday Clean Dandruff | PYRITHIONE ZINC | The Kroger Co. | 835270e7-ba6a-46e8-a617-f5df1c69d411 | 2026-02-27 | Warnings, Adverse reactions | M032 |
| Dry Scalp Care | PYRITHIONE ZINC | The Kroger Co. | 837d7a14-b312-4dce-a00a-623b50329378 | 2026-02-27 | Warnings, Adverse reactions | M032 |
| Everyday Clean | PYRITHIONE ZINC | The Kroger Co. | d442e1af-e31a-4de6-b358-52e08aedd7ee | 2026-02-27 | Warnings, Adverse reactions | M032 |
| Clean Apple | PYRITHIONE ZINC | The Kroger Co. | 00eb0594-cfa5-4fdb-aca8-650c10997924 | 2026-02-27 | Warnings, Adverse reactions | M032 |
| Dandruff | PYRITHIONE ZINC | Walmart Inc. | e4fd5d8b-a916-41c3-b05e-a32dd528f00f | 2026-02-27 | Warnings, Adverse reactions | M032 |
| Dry Scalp | PYRITHIONS ZINC | Walmart Inc. | 23ad86c0-5a75-4f52-8561-483708d415d6 | 2026-02-27 | Warnings, Adverse reactions | M032 |
| Everyday Clean 2 in 1 | PYRITHIONE ZINC | Walmart Inc. | 2bafcad7-1bb7-168e-e063-6394a90a0b9e | 2026-02-27 | Warnings, Adverse reactions | M032 |
| Paul Mitchell Dandruff | ZINC PYRITHIONE | John Paul Mitchell Systems | 4bc02aa8-86b1-985e-e063-6294a90aa267 | 2026-02-26 | Warnings | M032 |
| Dandruff | PYRITHIONE ZINC | H E B | bdf0b3da-db37-4996-b5e5-23cf824d1d1f | 2026-02-24 | Warnings, Adverse reactions | M032 |
| Dandruff | PYRITHIONE ZINC | H E B | 0927361e-a210-4e44-bbe7-fb68b240cf4f | 2026-02-24 | Warnings, Adverse reactions | M032 |
| Dry Scalp Care | PYRITHIONE ZINC | H E B | 0410f6a6-6602-44fb-b223-586439938e19 | 2026-02-24 | Warnings, Adverse reactions | M032 |
| Dry Scalp Dandruff | PYRITHIONE ZINC | H E B | 626933cb-9c84-4f37-943c-2a9bd21fcea5 | 2026-02-24 | Warnings, Adverse reactions | M032 |
| 2 in 1 Dandruff | PYRITHIONE ZINC | H E B | 75342eff-6bff-4fed-bd12-381edd2df681 | 2026-02-24 | Warnings, Adverse reactions | M032 |
| Dandruff | SELENIUM SULFIDE | H E B | 182ca790-0713-412a-9111-c0cf40f20d02 | 2026-02-24 | Warnings, Adverse reactions | M032 |
| Dandruff | PYRITHIONE ZINC | Better Living Brands, LLC | 03799050-cb2e-4c96-b177-55e6fc145d6b | 2026-02-23 | Warnings, Adverse reactions | M032 |
| Everyday Clean | PYRITHIONE ZINC | Perrigo Direct, Inc | c36e18cf-eec0-4972-b3b5-fe3865a438d8 | 2026-02-19 | Warnings, Adverse reactions | M032 |
| Everyday Clean Dandruff | PYRITHIONE ZINC | Meijer, Inc. | 34b80460-fcb9-42a8-b120-1558dc5093fa | 2026-02-19 | Warnings, Adverse reactions | M032 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 251400 | salicylic acid 2 % Topical Ointment | PSN | f62e6c5e-6e80-4b75-a0b1-c893224d9ce4 | 9 |
| 251400 | salicylic acid 0.02 MG/MG Topical Ointment | SCD | f62e6c5e-6e80-4b75-a0b1-c893224d9ce4 | 9 |
| 251400 | salicylic acid 2 % Topical Ointment | SY | f62e6c5e-6e80-4b75-a0b1-c893224d9ce4 | 9 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70794-207-14 | 70794020714 | 50 g in 1 TUBE (70794-207-14) | 50 g | 2016-06-29 | 0000-00-00 | No | No | Current |
| 70794-207-16 | 70794020716 | 59 g in 1 TUBE (70794-207-16) | 59 g | 2017-02-22 | 0000-00-00 | No | No | Current |
| 70794-207-17 | 70794020717 | 81 g in 1 TUBE (70794-207-17) | 81 g | 2017-02-22 | 0000-00-00 | No | No | Current |
| 70794-207-18 | 70794020718 | 103 g in 1 TUBE (70794-207-18) | 103 g | 2017-02-22 | 0000-00-00 | No | No | Current |